SARS-CoV-2 infection in kidney transplant recipients: clinical impact and outcomes - a single center experience.

Afonso SantosLuís Leite de SousaAna Rita Calça Anna LimaCélia NascimentoCristina JorgeTeresa AdragãoMargarida BrugesSusana PeresAndré Weigert

Published in: Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia (2021)

Among hospitalized patients, immunosuppression management included reduction or withdrawal of anti-metabolite and increase of corticosteroid dose. AKI occurred in almost half of patients and mortality in hospitalized patients reached 20%, reflecting greater disease severity than the general population.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
acute kidney injury
peritoneal dialysis
type diabetes
cardiovascular events
sars cov
metabolic syndrome
patient reported outcomes
cardiovascular disease
respiratory syndrome coronavirus
insulin resistance
glycemic control